Advanced search
Publication Cover
Blood Pressure Volume 16, 2007 - Issue 2
Submit an article Journal homepage
1,517
Views
105
CrossRef citations to date
0
Altmetric
Original

Exceptional early blood pressure control rates: The ACCOMPLISH trial

Kenneth Jamerson University of Michigan Health System, Ann Arbor, MichiganCorrespondence[email protected]
,
George L. Bakris University of Chicago‐Pritzker School of Medicine, Chicago, Illinois
,
Björn Dahlöf Sahlgrenska University Hospital, Gothenburg, Sweden
,
Bertram Pitt University of Michigan Health System, Ann Arbor, Michigan
,
Eric Velazquez Duke University School of Medicine, Durham, North Carolina
,
Jitendra Gupte Novartis Pharmaceuticals, East Hanover, New Jersey
,
Martin Lefkowitz Novartis Pharmaceuticals, East Hanover, New Jersey
,
Allen Hester Novartis Pharmaceuticals, East Hanover, New Jersey
,
Victor Shi Novartis Pharmaceuticals, East Hanover, New Jersey
,
Sverre E. Kjeldsen University of Michigan Health System, Ann Arbor, Michigan; Ullevaal University Hospital, Oslo, Norway
,
William Cushman University of Tennessee, College of Medicine, Memphis, Tennessee
,
Vasilios Papademetriou Georgetown University, Washington, DC
,
Michael Weber SUNY Downstate Medical College, Brooklyn, New York
,
Kenneth Jamerson University of Michigan Health System, Ann Arbor, MichiganCorrespondence[email protected]
,
George L. Bakris University of Chicago‐Pritzker School of Medicine, Chicago, Illinois
,
Björn Dahlöf Sahlgrenska University Hospital, Gothenburg, Sweden
,
Bertram Pitt University of Michigan Health System, Ann Arbor, Michigan
,
Eric Velazquez Duke University School of Medicine, Durham, North Carolina
,
Jitendra Gupte Novartis Pharmaceuticals, East Hanover, New Jersey
,
Martin Lefkowitz Novartis Pharmaceuticals, East Hanover, New Jersey
,
Allen Hester Novartis Pharmaceuticals, East Hanover, New Jersey
,
Victor Shi Novartis Pharmaceuticals, East Hanover, New Jersey
,
Sverre E. Kjeldsen University of Michigan Health System, Ann Arbor, Michigan; Ullevaal University Hospital, Oslo, Norway
,
William Cushman University of Tennessee, College of Medicine, Memphis, Tennessee
,
Vasilios Papademetriou Georgetown University, Washington, DC
&
Michael Weber SUNY Downstate Medical College, Brooklyn, New York
 show all
Pages 80-86 | Received 19 Mar 2007, Accepted 10 Apr 2007, Published online: 08 Jul 2009

Citations (105)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (24)

Yogita Rochlani, Mohammed Hasan Khan, Maciej Banach & Wilbert S. Aronow. (2017) Are two drugs better than one? A review of combination therapies for hypertension. Expert Opinion on Pharmacotherapy 18:4, pages 377-386.
Read now
Seok Heo, Geum Joo Yoo, Ji Yeon Choi, Hyoung Joon Park, Sung-Kwan Park & Sun Young Baek. (2016) A rapid method for the simultaneous determination of 25 anti-hypertensive compounds in dietary supplements using ultra-high-pressure liquid chromatography. Food Additives & Contaminants: Part A 33:11, pages 1627-1636.
Read now
Sverre E. Kjeldsen, Stevo Julius, Björn Dahlöf & Michael A. Weber. (2015) Physician (investigator) inertia in apparent treatment-resistant hypertension – Insights from large randomized clinical trials. Lennart Hansson Memorial Lecture. Blood Pressure 24:1, pages 1-6.
Read now
Roberto Fogari, Giuseppe Derosa, Annalisa Zoppi, Pierangelo Lazzari, Angela D'Angelo & Amedeo Mugellini. (2014) Comparative effect of canrenone or hydrochlorothiazide addition to valsartan/amlodipine combination on urinary albumin excretion in well-controlled type 2 diabetic hypertensive patients with microalbuminuria. Expert Opinion on Pharmacotherapy 15:4, pages 453-459.
Read now
Sverre E. Kjeldsen, Kenneth A. Jamerson, George L. Bakris, Bertram Pitt, Björn Dahlöf, Eric J. Velazquez, Tsushung A. Hua, Roxzana Y. Kelly, Dion Zappe, Allen Hester, Jaakko Tuomilehto, Jan Östergren, Hans Ibsen & Michael Weber. (2012) Predictors of systolic BP <140 mmHg and systolic BP level by randomly assigned treatment group (benazepril plus amlodipine or hydrochlorothiazide) in the ACCOMPLISH Study. Blood Pressure 21:2, pages 82-87.
Read now
Roberto Fogari, Annalisa Zoppi, Amedeo Mugellini, Paola Preti, Tiziano Perrone, Pamela Maffioli & Giuseppe Derosa. (2012) Effects of valsartan versus olmesartan addition to amlodipine/hydrochlorothiazide combination in treating stage 2 hypertensive patients. Expert Opinion on Pharmacotherapy 13:5, pages 629-636.
Read now
Sripal Bangalore & Ludwin Ley. (2012) Improving treatment adherence to antihypertensive therapy: the role of single-pill combinations. Expert Opinion on Pharmacotherapy 13:3, pages 345-355.
Read now
L. Breitscheidel, B. Ehlken, K. Kostev, M. S. A. Oberdiek, A. Sandberg & R. E. Schmieder. (2012) Real-life treatment patterns, compliance, persistence, and medication costs in patients with hypertension in Germany. Journal of Medical Economics 15:1, pages 155-165.
Read now
Daniel Duprez, Keith Ferdinand, Das Purkayastha, Rita Samuel & Richard Wright. (2011) Ambulatory blood pressure response to triple therapy with an angiotensin-receptor blocker (ARB), calcium-channel blocker (CCB), and HCTZ versus dual therapy with an ARB and HCTZ. Vascular Health and Risk Management 7, pages 701-708.
Read now
Tomasz Stompór, Maria Napora & Artur Olszewski. (2011) Renoprotective effects of benazepril: current perspective. Expert Review of Cardiovascular Therapy 9:6, pages 663-673.
Read now
Vivencio Barrios & Carlos Escobar. (2010) Antihypertensive and organ-protective effects of benazepril. Expert Review of Cardiovascular Therapy 8:12, pages 1653-1671.
Read now
Jean-Jacques Mourad, Sylvain Le Jeune, Anthony Pirollo, Clarisse Mourad, Yann Gaudouen & Marilucy Lopez-Sublet. (2010) Combinations of inhibitors of the renin–angiotensin system with calcium channel blockers for the treatment of hypertension: focus on perindopril/amlodipine. Current Medical Research and Opinion 26:9, pages 2263-2276.
Read now
Biff F. Palmer & Andrew Z. Fenves. (2010) Optimizing Blood Pressure Control in Patients with Chronic Kidney Disease. Baylor University Medical Center Proceedings 23:3, pages 239-245.
Read now
Shawna D. Nesbitt. (2010) Overcoming Therapeutic Inertia in Patients with Hypertension. Postgraduate Medicine 122:1, pages 118-124.
Read now
John M Flack & Robert Hilkert. (2009) Single-pill combination of amlodipine and valsartan in the management of hypertension. Expert Opinion on Pharmacotherapy 10:12, pages 1979-1994.
Read now
Giuliano Tocci, Francesca Palano, Erika Pagannone, Diana Chin, Andrea Ferrucci & Massimo Volpe. (2009) Fixed-combination therapies in hypertension management: focus on enalapril/lercanidipine. Expert Review of Cardiovascular Therapy 7:2, pages 115-123.
Read now
Thomas Philipp, Robert D. Glazer, Yanxing Zhao & Rainer Pospiech. (2009) Long-term tolerability and efficacy of the combination of amlodipine/valsartan in hypertensive patients: a 54-week, open-label extension study. Current Medical Research and Opinion 25:1, pages 187-193.
Read now
Eduardo Pimenta & Suzanne Oparil. (2008) Fixed combinations in the management of hypertension: patient perspectives and rationale for development and utility of the olmesartan – amlodipine combination. Vascular Health and Risk Management 4:3, pages 653-664.
Read now
Luis M. Ruilope & Julian Segura. (2008) The Importance of Integrated Risk Management When Treating Patients with Hypertension: Benefits of Angiotensin II Receptor Antagonist Therapy. Clinical and Experimental Hypertension 30:5, pages 397-414.
Read now
Luis M. Ruilope, Michel Burnier, Noemi Muszbek, Ruth E. Brown, Abdulkadir Keskinaslan, Philippe Ferber & Günter Harms. (2008) Public health value of fixed‐dose combinations in hypertension. Blood Pressure 17:sup1, pages 5-14.
Read now
Sverre E. Kjeldsen, Michael Weber, Suzanne Oparil & Kenneth A. Jamerson. (2008) Combining RAAS and calcium channel blockade: ACCOMPLISH in perspective. Blood Pressure 17:5-6, pages 260-269.
Read now
Sverre E. Kjeldsen, Thomas Hedner, Krzystof Narkiewicz & Suzanne Oparil. (2008) More is Less? Optimal Combination Therapy for Adequate Blood Pressure Lowering in Hypertension. Blood Pressure 17:3, pages 132-133.
Read now
Sverre E. Kjeldsen, Kenneth A. Jamerson, George L. Bakris, Bertram Pitt, Björn Dahlöf, Eric J. Velazquez, Jitendra Gupte, Linda Staikos, Tsushung A. Hua, Victor Shi, Allen Hester, Jaakko Tuomilehto, Jan Östergren, Hans Ibsen, Michael Weber & for the Avoiding Cardiovascular events through COMbination therapy in Patients LIving with Systolic Hypertension (ACCOMPLISH) Investigators. (2008) Predictors of blood pressure response to intensified and fixed combination treatment of hypertension: The ACCOMPLISH Study. Blood Pressure 17:1, pages 7-17.
Read now
Thomas Hedner, Sverre E. Kjeldsen, Krzysztof Narkiewicz & Susanne Oparil. (2007) Blood pressure control – Slowly getting there through new strategies?. Blood Pressure 16:2, pages 68-71.
Read now

Articles from other publishers (81)

Jorge A Sison. (2023) An Overview of the PRESYON 4 Trial and Its Impact on Practice. Journal of Asian Pacific Society of Cardiology 2.
Crossref
Zhiguo Wang & Baofeng YangZhiguo Wang & Baofeng Yang. 2022. Polypharmacology. Polypharmacology 323 342 .
Veronika Vejtasová, Jana Urbanová, Ludmila Brunerová, Michala Lustigová, Michael Jenšovský, Barbora Prýmková, Sabina Pálová & Jan Brož. (2021) Importance and efficiency of blood pressure control not only in type 2 diabetes patients. Vnitřní lékařství 67:4, pages 218-222.
Crossref
Xin Zheng, Huitao Gao, Xinge Cui, Yanbao Zhang, Rui Chen, Yaqin Wang, Pauline Lauruol & Hongyun Wang. (2021) Simultaneous determination of indapamide, perindopril and its active metabolite perindoprilat in human plasma using UPLC-MS/MS method. Journal of Chromatography B 1169, pages 122585.
Crossref
Anastasiia R. Denisova, Tatiana D. Solntseva, Olga A. Sivakova & Irina E. Chazova. (2021) Uncontrolled arterial hypertension: main causes, features of pathogenesis and approaches to treatment. Systemic Hypertension 18:1, pages 13-18.
Crossref
Donald J. WeaverJr.Jr., Anne Waldo, Gia J. Oh, Elaine S. Kamil, Matthew Elliott, Sharon Adler, Anne Pesenson, Meg M. Modes, Patrick Gipson, Richard A. Lafayette, David T. Selewski, Samara E. Attalla, Richard Eikstadt, Jonathan P. Troost, Debbie S. Gipson & Susan F. Massengill. (2020) Time to Initiation of Antihypertensive Therapy After Onset of Elevated Blood Pressure in Patients With Primary Proteinuric Kidney Disease. Kidney Medicine 2:2, pages 131-138.
Crossref
V. I. PodzolkovA. E. BraginaK. K. Osadchiy. (2019) Resistant Hypertension: Questions and Contemporary Answers. Rational Pharmacotherapy in Cardiology 15:4, pages 568-577.
Crossref
Robert M. Carey, David A. Calhoun, George L. Bakris, Robert D. Brook, Stacie L. Daugherty, Cheryl R. Dennison-Himmelfarb, Brent M. Egan, John M. Flack, Samuel S. Gidding, Eric Judd, Daniel T. Lackland, Cheryl L. Laffer, Christopher Newton-Cheh, Steven M. Smith, Sandra J. Taler, Stephen C. Textor, Tanya N. Turan & William B. White. (2018) Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association. Hypertension 72:5.
Crossref
Sergey V. Nedogoda & Vesna J. Stojanov. (2017) Single-Pill Combination of Perindopril/Indapamide/Amlodipine in Patients with Uncontrolled Hypertension: A Randomized Controlled Trial. Cardiology and Therapy 6:1, pages 91-104.
Crossref
O D Ostroumova, V V Vikentev, A G Abrosimov & E A Smoliarchuk. (2017) Dihydropyridine calcium antagonists: conscious choice. Systemic Hypertension 14:1, pages 61-68.
Crossref
Yuriy Sirenko & Ganna Radchenko. (2017) Impact of Statin Therapy on the Blood Pressure-Lowering Efficacy of a Single-Pill Perindopril/Amlodipine Combination in Hypertensive Patients with Hypercholesterolemia. High Blood Pressure & Cardiovascular Prevention 24:1, pages 85-93.
Crossref
Sinan Mutlu, Oktay Sari, Erol Arslan, Umit Aydogan, Yusuf C. Doganer & Bayram Koc. (2015) Comparison of ambulatory blood pressure measurement with home, office and pharmacy measurements: is arterial blood pressure measured at pharmacy reliable?. Journal of Evaluation in Clinical Practice 22:1, pages 40-45.
Crossref
Carolyn H. Still, Timothy E. Craven, Barry I. Freedman, Peter N. Van Buren, Kaycee M. Sink, Anthony A. Killeen, Jeffrey T. Bates, Alberta Bee, Gabriel Contreras, Suzanne Oparil, Carolyn M. Pedley, Barry M. Wall, Suzanne White, Delia M. Woods, Carlos J. Rodriguez & Jackson T. WrightJr.Jr.. (2015) Baseline characteristics of African Americans in the Systolic Blood Pressure Intervention Trial. Journal of the American Society of Hypertension 9:9, pages 670-679.
Crossref
Ilaria Spoletini, Cristiana Vitale & Giuseppe M. C. Rosano. 2015. ACEi and ARBS in Hypertension and Heart Failure. ACEi and ARBS in Hypertension and Heart Failure 119 148 .
Samir G Mallat, Serena Abu Samra, Fariha Younes & Marie-Thérèse Sawaya. (2014) Identifying predictors of blood pressure control in the Lebanese population - a national, multicentric survey – I-PREDICT. BMC Public Health 14:1.
Crossref
Tonya Lynn Breaux-Shropshire, Lauren Whitt, Russell L. Griffin, Angele Trenese Shropshire & David A. Calhoun. (2014) Characterizing Workers Participating in a Worksite Wellness Health Screening Program Using Blood Pressure Control, Self-Monitoring, Medication Adherence, Depression, and Exercise. Workplace Health & Safety 62:7, pages 292-300.
Crossref
Tonya Lynn Breaux-Shropshire, Lauren Whitt, Russell L. Griffin, Angele Trenese Shropshire & David A. Calhoun. (2016) Characterizing Workers Participating in a Worksite Wellness Health Screening Program Using Blood Pressure Control, Self-Monitoring, Medication Adherence, Depression, and Exercise. Workplace Health & Safety 62:7, pages 292-300.
Crossref
George Bakris, Pantelis Sarafidis, Rajiv Agarwal & Luis Ruilope. (2014) Review of blood pressure control rates and outcomes. Journal of the American Society of Hypertension 8:2, pages 127-141.
Crossref
Alexandra M. Kuhn-Thiel, Christel Weiß & Martin Wehling. (2013) Consensus Validation of the FORTA (Fit fOR The Aged) List: A Clinical Tool for Increasing the Appropriateness of Pharmacotherapy in the Elderly. Drugs & Aging 31:2, pages 131-140.
Crossref
Benjamin J. Epstein, Niren K. Shah & Nancy L. Borja-Hart. (2013) Management of hypertension with fixed-dose triple-combination treatments. Therapeutic Advances in Cardiovascular Disease 7:5, pages 246-259.
Crossref
Ji-Guang Wang, Wei-Fang Zeng, Yu-Song He, Liang-Long Chen, Meng Wei, Zhao-Ping Li, Bao-Wei Zhang & Yan Li. (2013) Valsartan/Amlodipine Compared to Nifedipine GITS in Patients with Hypertension Inadequately Controlled by Monotherapy. Advances in Therapy 30:8, pages 771-783.
Crossref
S. H. Hong, J. Wang & J. Tang. (2013) Dynamic View on Affordability of Fixed-Dose Combination Antihypertensive Drug Therapy. American Journal of Hypertension 26:7, pages 879-887.
Crossref
Mohsen A. Hedaya & Sally A. Helmy. (2013) Pharmacokinetic Interactions of Valsartan and Hydrochlorothiazide: An Open-Label, Randomized, 4-Period Crossover Study in Healthy Egyptian Male Volunteers. Clinical Therapeutics 35:6, pages 846-861.
Crossref
Andreas Hagendorff, Siegfried Freytag, Alfons Müller & Sven Klebs. (2013) Pill Burden in Hypertensive Patients Treated with Single-Pill Combination Therapy — An Observational Study. Advances in Therapy 30:4, pages 406-419.
Crossref
Serife Evrim Kepekci Tekkeli. (2013) Development of an HPLC-UV Method for the Analysis of Drugs Used for Combined Hypertension Therapy in Pharmaceutical Preparations and Human Plasma. Journal of Analytical Methods in Chemistry 2013, pages 1-10.
Crossref
Anthony S. Wierzbicki & Adie Viljoen. 2012. Cardiovascular Disease and Health in the Older Patient. Cardiovascular Disease and Health in the Older Patient 44 67 .
Giovanni Corrao, Federica Nicotra, Andrea Parodi, Antonella Zambon, Davide Soranna, Franca Heiman, Luca Merlino & Giuseppe Mancia. (2012) External adjustment for unmeasured confounders improved drug–outcome association estimates based on health care utilization data. Journal of Clinical Epidemiology 65:11, pages 1190-1199.
Crossref
Karen L. Margolis, Tessa J. Kerby, Stephen E. Asche, Anna R. Bergdall, Michael V. Maciosek, Patrick J. O'Connor & JoAnn M. Sperl-Hillen. (2012) Design and rationale for Home Blood Pressure Telemonitoring and Case Management to Control Hypertension (HyperLink): A cluster randomized trial. Contemporary Clinical Trials 33:4, pages 794-803.
Crossref
Jing‐He Yan, Venkateswar Jarugula, Ron Sabo, Cheraz Cherif Papst, Jack Zhang & William P. Dole. (2013) Pharmacokinetics and Pharmacodynamics of Aliskiren/Hydrochlorothiazide Single‐Pill Combination Tablets and Free Combination of Aliskiren and Hydrochlorothiazide. The Journal of Clinical Pharmacology 52:5, pages 645-655.
Crossref
Anthony S. Wierzbicki & Adie Viljoen. 2012. Pathy's Principles and Practice of Geriatric Medicine. Pathy's Principles and Practice of Geriatric Medicine 471 482 .
Giovanni CorraoFederica NicotraAndrea ParodiAntonella ZambonFranca HeimanLuca MerlinoIda FortinoGiancarlo CesanaGiuseppe Mancia. (2011) Cardiovascular Protection by Initial and Subsequent Combination of Antihypertensive Drugs in Daily Life Practice. Hypertension 58:4, pages 566-572.
Crossref
Richard F. Wright, Daniel Duprez, Das Purkayastha, Rita Samuel & Keith C. Ferdinand. (2011) Combination Angiotensin-Receptor Blocker (ARB)/Calcium Channel Blocker With HCTZ vs the Maximal Recommended Dose of an ARB With HCTZ in Patients With Stage 2 Hypertension: The Exforge As Compared to Losartan Treatment in Stage 2 Systolic Hypertension (EXA. The Journal of Clinical Hypertension 13:8, pages 588-597.
Crossref
Teryl K. Nuckols, Julia E. Aledort, John Adams, Julie Lai, Myong-Hyun Go, Joan Keesey & Elizabeth McGlynn. (2011) Cost Implications of Improving Blood Pressure Management among U.S. Adults. Health Services Research 46:4, pages 1124-1157.
Crossref
Prafulla Bhad, Surya Ayalasomayajula, Rajesh Karan, Selene Leon, Gillies-Jacques Riviere, Gangadhar Sunkara & Venkateswar Jarugula. (2011) Evaluation of Pharmacokinetic Interactions Between Amlodipine, Valsartan, and Hydrochlorothiazide in Patients With Hypertension. The Journal of Clinical Pharmacology 51:6, pages 933-942.
Crossref
M R Weir, D Zappe, L A Orloski & J R Sowers. (2010) How early should blood pressure control be achieved for optimal cardiovascular outcomes?. Journal of Human Hypertension 25:4, pages 211-217.
Crossref
Alan H. Gradman, Jan N. Basile, Barry L. Carter & George L. Bakris. (2011) Combination Therapy in Hypertension. The Journal of Clinical Hypertension 13:3, pages 146-154.
Crossref
Anastasios Makris, Maria Seferou & Dimitris P. Papadopoulos. (2011) Resistant Hypertension Workup and Approach to Treatment. International Journal of Hypertension 2011, pages 1-10.
Crossref
Henry R. BlackAndreas KribbenFernando Aguirre PalaciosMahendra BijarniaAnnik K. LaflammeFabio Baschiera. (2010) Aliskiren Alone or in Combination With Hydrochlorothiazide in Patients With the Lower Ranges of Stage 2 Hypertension: The ACQUIRE Randomized Double‐Blind Study. The Journal of Clinical Hypertension 12:12, pages 917-926.
Crossref
Tomás Romero & Camila X. Romero. (2010) Prevención cardiovascular estancada: tendencias alarmantes y barreras socioeconómicas persistentes. Revista Española de Cardiología 63:11, pages 1340-1348.
Crossref
Pedro Marques da Silva. (2010) Efficacy of Fixed-Dose Combination Therapy in the Treatment of Patients with Hypertension. Clinical Drug Investigation 30:9, pages 625-641.
Crossref
Henry PunziJoel M. Neutel, Dean J. Kereiakes, Ali Shojaee, William F. Waverczak, Robert Dubiel & Jen-Fue Maa. (2010) Efficacy of amlodipine and olmesartan medoxomil in patients with hypertension: the AZOR Trial Evaluating Blood Pressure Reductions and Control (AZTEC) study. Therapeutic Advances in Cardiovascular Disease 4:4, pages 209-221.
Crossref
D H Zappe, B F Palmer, D A Calhoun, D Purkayastha, R Samuel & K A Jamerson. (2009) Effectiveness of initiating treatment with valsartan/hydrochlorothiazide in patients with stage-1 or stage-2 hypertension. Journal of Human Hypertension 24:7, pages 483-491.
Crossref
Daniel T. Lackland. (2010) The Role of Combination Therapy for Hypertension After ACCOMPLISH. Current Cardiovascular Risk Reports 4:4, pages 251-255.
Crossref
Dan R. Berlowitz & Stanley Franklin. (2010) The Clock Is Ticking: The Case for Achieving More Rapid Control of Hypertension. The Journal of Clinical Hypertension 12:5, pages 323-327.
Crossref
Jan BasileJoel Neutel. (2009) Overcoming clinical inertia to achieve blood pressure goals: the role of fixed-dose combination therapy. Therapeutic Advances in Cardiovascular Disease 4:2, pages 119-127.
Crossref
Jan A. StaessenTom RichartZengwu WangLutgarde Thijs. (2010) Implications of Recently Published Trials of Blood Pressure–Lowering Drugs in Hypertensive or High-Risk Patients. Hypertension 55:4, pages 819-831.
Crossref
John B Kostis. (2010) Antihypertensive Therapy With CCB/ARB Combination in Older Individuals: Focus on Amlodipine/Valsartan Combination. American Journal of Therapeutics 17:2, pages 188-196.
Crossref
Alan H. Gradman, Jan N. Basile, Barry L. Carter & George L. Bakris. (2010) Combination therapy in hypertension. Journal of the American Society of Hypertension 4:2, pages 90-98.
Crossref
R. Düsing. (2010) Aktuelle Aspekte der Kombinationstherapie bei HypertonieCurrent aspects of combination therapy in hypertension. Der Kardiologe 4:1, pages 27-36.
Crossref
Alan H. Gradman, Jan N. Basile, Barry L. Carter & George L. Bakris. (2010) Combination therapy in hypertension. Journal of the American Society of Hypertension 4:1, pages 42-50.
Crossref
Tomas Romero & Camila X. Romero. (2010) Stagnant Cardiovascular Prevention: Alarming Trends and Persistent Socioeconomic Hurdles. Revista Española de Cardiología (English Edition) 63:11, pages 1340-1348.
Crossref
Jan Basile. (2009) Clinical Inertia and Blood Pressure Goal Attainment. The Journal of Clinical Hypertension 11, pages S5-S12.
Crossref
N. L. Zaharan, A. Mahmud, K. Bennett & J. Feely. (2009) Hypertension in Ireland: public awareness and doctors choice of therapy. Irish Journal of Medical Science 178:4, pages 413-417.
Crossref
Matthew R. Weir, Fawn Yeh, Angela Silverman, Richard B. Devereux, James M. Galloway, Jeffrey A. Henderson, William J. Howard, Marie Russell, Charlton Wilson, Robert Ratner, John Sorkin, Jason G. Umans, Jerome L. Fleg, Mario Stylianou, Elisa Lee & Barbara V. Howard. (2009) Safety and Feasibility of Achieving Lower Systolic Blood Pressure Goals in Persons With Type 2 Diabetes: The SANDS Trial. The Journal of Clinical Hypertension 11:10, pages 540-548.
Crossref
Mary Ellen Roberts & Benjamin J. Epstein. (2009) Optimizing Management of Hypertension With Combination Therapy. Journal of Cardiovascular Nursing 24:5, pages 380-389.
Crossref
William J. Elliott. (2009) Improving Outcomes in Hypertensive Patients: Focus on Adherence and Persistence With Antihypertensive Therapy. The Journal of Clinical Hypertension 11:7, pages 376-382.
Crossref
E. I. Astashkin & M. Glezer. (2009) Cardiac lipotoxic effects of obesity. "Arterial’naya Gipertenziya" ("Arterial Hypertension") 15:3, pages 335-341.
Crossref
M. Burnier, R. E. Brown, S. H. Ong, A. Keskinaslan & Z. M. Khan. (2009) Issues in blood pressure control and the potential role of single-pill combination therapies. International Journal of Clinical Practice 63:5, pages 790-798.
Crossref
Barry L. Carter. (2009) Fixed-Dosed Combinations Are Not Indicated as Initial Therapy: A Debate. The Journal of Clinical Hypertension 11:2, pages 94-99.
Crossref
S S Franklin & J M Neutel. (2008) Initial combination therapy for rapid and effective control of moderate and severe hypertension. Journal of Human Hypertension 23:1, pages 4-11.
Crossref
George L. Bakris, James R. Sowers & Keith C. Ferdinand. (2008) Blood Pressure Control in the Patient With Difficult-to-Control Hypertension: Which Agent for Which Patient?. Preventive Cardiology 11:1, pages 42-49.
Crossref
Fadia T. Shaya, Dongyi Du, Feride Frech-Tamas, Helen Lau, Hugh Fatodu & Howard Garber. (2008) Predictors of fixed-dose combination antihypertensive drug therapy in a Medicaid population. Journal of the American Society of Hypertension 2:6, pages 469-475.
Crossref
Pantelis A. Sarafidis & George L. Bakris. (2008) Resistant Hypertension. Journal of the American College of Cardiology 52:22, pages 1749-1757.
Crossref
Norman M. Kaplan. (2008) Recent Clinical Trials. Hypertension 52:4, pages 608-609.
Crossref
William C. Cushman, Charles E. Ford, Paula T. Einhorn, Jackson T. Wright Jr, Richard A. Preston, Barry R. Davis, Jan N. Basile, Paul K. Whelton, Robert J. Weiss, Arnaud Bastien, Donald L. Courtney, Bruce P. Hamilton, Kent Kirchner, Gail T. Louis, Tamrat M. Retta & Donald G. Vidt. (2008) Blood Pressure Control by Drug Group in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). The Journal of Clinical Hypertension 10:10, pages 751-760.
Crossref
A V Barsukov, I A Vasil'eva & S B Shustov. (2008) Postprandial'noe snizhenie arterial'nogo davleniya u patsientov s essentsial'noy arterial'noy gipertenziey: aktual'nye voprosy patogeneza i lecheniya. Systemic Hypertension 5:3, pages 18-24.
Crossref
George Bakris, Allen Hester, Michael Weber, Bjorn Dahlof, Bert Pitt, Eric Velasquez, Linda Staikos‐Byrne, Victor Shi & Ken Jamerson. (2008) The Diabetes Subgroup Baseline Characteristics of the Avoiding Cardiovascular Events Through Combination Therapy in Patients Living With Systolic Hypertension (ACCOMPLISH) Trial. Journal of the CardioMetabolic Syndrome 3:4, pages 229-233.
Crossref
Jan N. Basile. (2008) Rationale for Fixed-Dose Combination Therapy to Reach Lower Blood Pressure Goals. Southern Medical Journal 101:9, pages 918-924.
Crossref
Apurv Khanna, Lance Lefkowitz & William B White. (2008) Evaluation of recent fixed-dose combination therapies in the management of hypertension. Current Opinion in Nephrology and Hypertension 17:5, pages 477-483.
Crossref
Dimitris P Papadopoulos & Vasilios Papademetriou. (2008) Aggressive blood pressure control and stroke prevention: role of calcium channel blockers. Journal of Hypertension 26:5, pages 844-852.
Crossref
A. Konradi. (2008) Not only the effective, but a rapid blood pressure reduction as a novel aim in hypertension treatment. The role of combination therapy. "Arterial’naya Gipertenziya" ("Arterial Hypertension") 14:2, pages 137-142.
Crossref
William B. White. (2008) Improving blood pressure control and clinical outcomes through initial use of combination therapy in stage 2 hypertension. Blood Pressure Monitoring 13:2, pages 123-129.
Crossref
Boris Gojanovic, François Feihl, Lucas Liaudet & Bernard Waeber. (2008) Review: Concomitant calcium entry blockade and inhibition of the renin-angiotensin system: a rational and effective means for treating hypertension. Journal of the Renin-Angiotensin-Aldosterone System 9:1, pages 1-9.
Crossref
Matthew R. Weir & George L. Bakris. (2008) Combination Therapy With Renin-Angiotensin-Aldosterone Receptor Blockers for Hypertension: How Far Have We Come?. The Journal of Clinical Hypertension 10:2, pages 146-152.
Crossref
Pantelis A. Sarafidis & George L. Bakris. (2008) State of Hypertension Management in the United States: Confluence of Risk Factors and the Prevalence of Resistant Hypertension. The Journal of Clinical Hypertension 10:2, pages 130-139.
Crossref
Kenneth A. Jamerson & Jan Basile. (2008) Prompt, Aggressive BP Lowering in High-Risk Patients. The Journal of Clinical Hypertension 10:s1, pages 40-48.
Crossref
George L. Bakris. (2008) Combined Therapy With a Calcium Channel Blocker and an Angiotensin II Type 1 Receptor Blocker. The Journal of Clinical Hypertension 10:s1, pages 27-32.
Crossref
Jan Basile. (2008) The Importance of Prompt Blood Pressure Control. The Journal of Clinical Hypertension 10:s1, pages 13-19.
Crossref
Michael A. Weber & Nanette K. Wenger. (2008) Progress in Treating Hypertension. The American Journal of Geriatric Cardiology 17:1, pages 5-6.
Crossref
Michael A. Weber. (2007) The Evolution of Combination Therapy in Treating Hypertension. The Journal of Clinical Hypertension 9:s12, pages 1-4.
Crossref
Joshua Barzilay, Richard Grimm, William Cushman, Alain G. Bertoni & Jan Basile. (2007) Getting to Goal Blood Pressure: Why Reserpine Deserves a Second Look. The Journal of Clinical Hypertension 9:8, pages 591-594.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.